Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs

MLA

Taur, S., et al. “Association of Polymorphisms of CYP2C9, CYP2C19, and ABCB1, and Activity of P-Glycoprotein with Response to Anti-Epileptic Drugs.” Journal of Postgraduate Medicine, vol. 60, no. 3, July 2014, p. 265. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.381620886&authtype=sso&custid=ns315887.

APA

Taur, S., Kulkarni, N., Gandhe, P., Thelma, B., Ravat, S., Gogtay, N., & Thatte, U. (2014, July 1). Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs. Journal of Postgraduate Medicine, 60(3), 265.

Chicago

Taur, S., N. Kulkarni, P. Gandhe, B. Thelma, S. Ravat, N. Gogtay, and U. Thatte. 2014. “Association of Polymorphisms of CYP2C9, CYP2C19, and ABCB1, and Activity of P-Glycoprotein with Response to Anti-Epileptic Drugs.” Journal of Postgraduate Medicine, July 1. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.381620886&authtype=sso&custid=ns315887.